[HTML][HTML] Targeting the insulin-like growth factor pathway in hepatocellular carcinoma

M Enguita-Germán, P Fortes - World journal of hepatology, 2014 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths
worldwide. Only 30%-40% of the patients with HCC are eligible for curative treatments …

The regulation of Hox gene expression during animal development

M Mallo, CR Alonso - Development, 2013 - journals.biologists.com
Hox genes encode a family of transcriptional regulators that elicit distinct developmental
programmes along the head-to-tail axis of animals. The specific regional functions of …

MicroRNAs in the pathogenesis of hepatocellular carcinoma: A review

A Morishita, K Oura, T Tadokoro, K Fujita, J Tani… - Cancers, 2021 - mdpi.com
Simple Summary Hepatocellular carcinoma (HCC) is one of the most frequently occurring
cancers, and the prognosis for late-stage HCC remains poor. A better understanding of the …

Circulating microRNAs in hepatocellular carcinoma: potential diagnostic and prognostic biomarkers

H Reza Mirzaei, A Sahebkar… - Current …, 2016 - ingentaconnect.com
Hepatocellular carcinoma (HCC) is one of the most common types of malignancies
worldwide. There is little information on the mechanisms involved in the pathogenesis of this …

High mobility group box 1 in human cancer

BL Rapoport, HC Steel, AJ Theron, L Heyman, T Smit… - Cells, 2020 - mdpi.com
High mobility group box 1 (HMGB1) is an extremely versatile protein that is located
predominantly in the nucleus of quiescent eukaryotic cells, where it is critically involved in …

Hsa_circRNA_002144 promotes growth and metastasis of colorectal cancer through regulating miR-615-5p/LARP1/mTOR pathway

M Wu, C Kong, M Cai, W Huang, Y Chen… - …, 2021 - academic.oup.com
CircRNAs (circular RNAs), recently identified as a critical regulator in tumorigenesis,
participate in CRC (colorectal cancer) growth. However, the role of hsa_circRNA_002144 in …

mi RNA in hepatocellular carcinoma

A Morishita, T Masaki - Hepatology Research, 2015 - Wiley Online Library
Hepatocellular carcinoma (HCC) is the third leading cause of cancer deaths worldwide.
Despite improvements in HCC therapy, the prognosis for HCC patients remains poor due to …

Insulin-like growth factor-2 (IGF-2) in fibrosis

Y Zhu, L Chen, B Song, Z Cui, G Chen, Z Yu, B Song - Biomolecules, 2022 - mdpi.com
The insulin family consists of insulin, insulin-like growth factor 1 (IGF-1), insulin-like growth
factor 2 (IGF-2), their receptors (IR, IGF-1R and IGF-2R), and their binding proteins. All three …

MicroRNA-486-5p enhances hepatocellular carcinoma tumor suppression through repression of IGF-1R and its downstream mTOR, STAT3 and c-Myc

RA Youness, HM El-Tayebi, RA Assal… - Oncology …, 2016 - spandidos-publications.com
The insulin-like growth factor (IGF)-axis has been paradigmatically involved in
hepatocellular carcinoma (HCC) tumor initiation, progression and drug resistance …

MicroRNAs in hepatocellular carcinoma: regulation, function, and clinical implications

J Sun, H Lu, X Wang, H Jin - The Scientific World Journal, 2013 - Wiley Online Library
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide and the
third cause of cancer‐related death. Poor understanding of the mechanisms underlying the …